Fendiline Hydrochloride
Suppliers
Names
[ CAS No. ]:
13636-18-5
[ Name ]:
Fendiline Hydrochloride
[Synonym ]:
Fendiline hydrochloride
Fendiline (hydrochloride)
Chemical & Physical Properties
[ Density]:
1.031g/cm3
[ Boiling Point ]:
452.1ºC at 760mmHg
[ Molecular Formula ]:
C23H26ClN
[ Molecular Weight ]:
351.91200
[ Flash Point ]:
207.9ºC
[ Exact Mass ]:
351.17500
[ PSA ]:
12.03000
[ LogP ]:
6.75230
[ Vapour Pressure ]:
2.3E-08mmHg at 25°C
[ Storage condition ]:
-20℃
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- DP4790000
- CHEMICAL NAME :
- Benzylamine, N-(3,3-diphenylpropyl)-alpha-methyl-, hydrochloride
- CAS REGISTRY NUMBER :
- 13636-18-5
- LAST UPDATED :
- 199601
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C23-H25-N.Cl-H
- MOLECULAR WEIGHT :
- 351.95
- WISWESSER LINE NOTATION :
- 1YR&M2YR&R &GH
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 950 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3262977
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 14500 ug/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3262977
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xn: Harmful;
[ Risk Phrases ]:
R22
[ Safety Phrases ]:
36
[ RIDADR ]:
NONH for all modes of transport
[ RTECS ]:
DP4790000
Articles
PLoS Negl. Trop. Dis. 9 , e0003962, (2015)
As plans to expand mass drug treatment campaigns to fight schistosomiasis form, worries about reliance on praziquantel as the sole available treatment motivate the investigation for novel antischistos...